| Previous Close | 7.10 |
| Open | 7.10 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 7.02 - 7.50 |
| 52 Week Range | 5.90 - 25.17 |
| Volume | 677,218 |
| Avg. Volume | 1,058,306 |
| Market Cap | 213.06M |
| Beta | 2.40 |
| PE Ratio (TTM) | -2.57 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Motley Fool•7 days ago
These 3 Biotechs Have Been Crushed; Is It Time to Bargain Shop?
Disappointing trials from XBiotech, Merrimack Pharmaceuticals, and NewLink Genetics have earned the market's ire. But are their declines overdone?
- Motley Fool•10 days ago
A Surprising Disappointment Derails NewLink Genetics -- What's Next?
Roche Holdings has decided to walk away from co-developing NewLink Genetics IDO-inhibitor, GDC-0919.
- Zacks•16 days ago
Are Options Traders Betting on a Big Move in NewLink (NLNK) Stock?
NewLink (NLNK) needs Investors to pay close attention to the stock based on moves in the options market lately.
